Evaluation of pegaspargase (PEG-ASP) adverse events among adolescents and young adults (AYAs) and younger patients with lymphoid malignancies (LM) at the Children’s Hospital of Eastern Ontario (CHEO).

Nicole Mathies,Isabelle Laforest,Kenneth Tang,Geneviève Goulet,Lesleigh S. Abbott

Evaluation of pegaspargase (PEG-ASP) adverse events among adolescents and young adults (AYAs) and younger patients with lymphoid malignancies (LM) at the Children’s Hospital of Eastern Ontario (CHEO).

2018

Nicole Mathies
Isabelle Laforest
Kenneth Tang
Geneviève Goulet
Lesleigh S. Abbott

10531Background: PEG-ASP is a common component of the chemotherapy regime for LM, but with significant side effects. The aim of this study was to determine the prevalence of major adverse events: a...

Keywords:

Physical therapy
Young adult
Medicine
Adverse effect
Pegaspargase
Pediatrics
Chemotherapy
PEG ratio

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations